Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10%
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, on Friday reported a net loss for the second quarter of 2024, reflecting a […]
The post Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10% first appeared on AlphaStreet.